Latest News about REGN
Recent news which mentions REGN
   Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
   
  
  
  September 30, 2021
  From Benzinga
 
   Why Shares of Editas Medicine Are Lower This Morning
   
  
  
  September 29, 2021
  From Motley Fool
 
   7 Biotech Stocks Entering the Golden Boom Phase
   
  
  
  September 28, 2021
  From InvestorPlace
 
   Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
   
  
  
  September 28, 2021
  From Benzinga
 
   Will Moderna Stock Reach $500?
   
  
  
  September 28, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
   
  
  
  September 28, 2021
  From Benzinga
 
   Breaking Down CRISPR Technology
   
  
  
  September 28, 2021
  From Motley Fool
 
   3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
   
  
  
  September 28, 2021
  From Motley Fool
 
   Glaxo - Vir Biotech's COVID Treatment Approved In Japan
   
  
  
  September 27, 2021
  From Benzinga
 
   Could AbbVie's New Collaboration Be a Blockbuster?
   
  
  
  September 27, 2021
  From Motley Fool
 
   3 Top Biotech Stocks to Buy for the Long Haul
   
  
  
  September 27, 2021
  From Motley Fool
 
   WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
   
  
  
  September 24, 2021
  From Benzinga
 
   CDC head overrules advisers to allow COVID-19 boosters be offered to at-risk workers, and Biden urges eligible to act fast
   
  
  
  September 24, 2021
  From MarketWatch
 
   Here's Why I Bought This Recent Genetics IPO
   
  
  
  September 22, 2021
  From Motley Fool
 
   Where to Invest $100 Right Now
   
  
  
  September 22, 2021
  From Motley Fool
 
   NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?
   
  
  
  September 21, 2021
  From InvestorPlace
 
   3 COVID Stocks to Buy in a Bear Market
   
  
  
  September 21, 2021
  From Motley Fool
 
   Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
   
  
  
  September 20, 2021
  From Benzinga
 
   AbbVie's Pain Is Sanofi's and Regeneron's Gain
   
  
  
  September 18, 2021
  From Motley Fool
 
   Smart Investors Are Watching This Trend Right Now
   
  
  
  September 16, 2021
  From Motley Fool
 
   7 Gene Editing Stocks Promising to Change our DNA
   
  
  
  September 15, 2021
  From InvestorPlace
 
   Alaska joins Idaho in rationing health care as hospitals are packed with COVID patients, and WHO says Africa is being left behind in vaccine push
   
  
  
  September 15, 2021
  From MarketWatch
 
   Breaking Down The Inflation Numbers Draws Attention To Oil Prices
   
  
  
  September 15, 2021
  From Benzinga
 
   10 Biggest Price Target Changes For Wednesday
   
  
  
  September 15, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
   
  
  
  September 15, 2021
  From Benzinga
 
   These Promising Clinical Results Could Be Huge for Amgen Investors
   
  
  
  September 11, 2021
  From Motley Fool
 
   Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?
   
  
  
  September 11, 2021
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
